U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

No progression to cancer

MedGen UID:
409675
•Concept ID:
C1968778
•
Finding

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVNo progression to cancer

Professional guidelines

PubMed

A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin.
Fayter D, Corbett M, Heirs M, Fox D, Eastwood A
Health Technol Assess 2010 Jul;14(37):1-288. doi: 10.3310/hta14370. PMID: 20663420

Recent clinical studies

Etiology

MicroRNA: A signature for cancer progression.
Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S
Biomed Pharmacother 2021 Jun;138:111528. Epub 2021 Mar 23 doi: 10.1016/j.biopha.2021.111528. PMID: 33770669
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U
Front Immunol 2020;11:1280. Epub 2020 Aug 7 doi: 10.3389/fimmu.2020.01280. PMID: 32849491Free PMC Article
Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation.
Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA
J Clin Oncol 2016 Dec 10;34(35):4270-4276. Epub 2016 Nov 7 doi: 10.1200/JCO.2016.67.4283. PMID: 27903155Free PMC Article
Pancreatic Cancer: Pathogenesis and Diagnosis.
Goral V
Asian Pac J Cancer Prev 2015;16(14):5619-24. doi: 10.7314/apjcp.2015.16.14.5619. PMID: 26320426
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J
Eur J Cancer 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026. PMID: 19097774

Diagnosis

MicroRNA: A signature for cancer progression.
Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S
Biomed Pharmacother 2021 Jun;138:111528. Epub 2021 Mar 23 doi: 10.1016/j.biopha.2021.111528. PMID: 33770669
Intratumoral heterogeneity in cancer progression and response to immunotherapy.
Vitale I, Shema E, Loi S, Galluzzi L
Nat Med 2021 Feb;27(2):212-224. Epub 2021 Feb 11 doi: 10.1038/s41591-021-01233-9. PMID: 33574607
Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L, Kistenmacher AK, Suo H, Kitte R, Dluczek S, Strauß A, Blaudszun AR, Yevsa T, Fricke S, Kossatz-Boehlert U
Front Immunol 2020;11:1280. Epub 2020 Aug 7 doi: 10.3389/fimmu.2020.01280. PMID: 32849491Free PMC Article
Role of interleukin-6 in cancer progression and therapeutic resistance.
Kumari N, Dwarakanath BS, Das A, Bhatt AN
Tumour Biol 2016 Sep;37(9):11553-11572. Epub 2016 Jun 3 doi: 10.1007/s13277-016-5098-7. PMID: 27260630
Pancreatic Cancer: Pathogenesis and Diagnosis.
Goral V
Asian Pac J Cancer Prev 2015;16(14):5619-24. doi: 10.7314/apjcp.2015.16.14.5619. PMID: 26320426

Therapy

Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials.
Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, Liu Z, Yang L, Jiang Q, Cheng Q, Luo P, Liu G
Mol Cancer 2023 Oct 2;22(1):159. doi: 10.1186/s12943-023-01860-5. PMID: 37784082Free PMC Article
Brachytherapy: An overview for clinicians.
Chargari C, Deutsch E, Blanchard P, Gouy S, Martelli H, Guérin F, Dumas I, Bossi A, Morice P, Viswanathan AN, Haie-Meder C
CA Cancer J Clin 2019 Sep;69(5):386-401. Epub 2019 Jul 30 doi: 10.3322/caac.21578. PMID: 31361333
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Mereiter S, Balmaña M, Campos D, Gomes J, Reis CA
Cancer Cell 2019 Jul 8;36(1):6-16. doi: 10.1016/j.ccell.2019.06.006. PMID: 31287993
Response Assessment in Neuro-Oncology Clinical Trials.
Wen PY, Chang SM, Van den Bent MJ, Vogelbaum MA, Macdonald DR, Lee EQ
J Clin Oncol 2017 Jul 20;35(21):2439-2449. Epub 2017 Jun 22 doi: 10.1200/JCO.2017.72.7511. PMID: 28640707Free PMC Article
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J
Eur J Cancer 2009 Jan;45(2):228-47. doi: 10.1016/j.ejca.2008.10.026. PMID: 19097774

Prognosis

Epidemiology and Prevention of Prostate Cancer.
Gandaglia G, Leni R, Bray F, Fleshner N, Freedland SJ, Kibel A, Stattin P, Van Poppel H, La Vecchia C
Eur Urol Oncol 2021 Dec;4(6):877-892. Epub 2021 Oct 26 doi: 10.1016/j.euo.2021.09.006. PMID: 34716119
Definition, Incidence, and Challenges for Assessment of Hyperprogressive Disease During Cancer Treatment With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.
Park HJ, Kim KW, Won SE, Yoon S, Chae YK, Tirumani SH, Ramaiya NH
JAMA Netw Open 2021 Mar 1;4(3):e211136. doi: 10.1001/jamanetworkopen.2021.1136. PMID: 33760090Free PMC Article
Progress in cancer mortality, incidence, and survival: a global overview.
Santucci C, Carioli G, Bertuccio P, Malvezzi M, Pastorino U, Boffetta P, Negri E, Bosetti C, La Vecchia C
Eur J Cancer Prev 2020 Sep;29(5):367-381. doi: 10.1097/CEJ.0000000000000594. PMID: 32740162
Hyperprogression under Immunotherapy.
Frelaut M, Le Tourneau C, Borcoman E
Int J Mol Sci 2019 May 30;20(11) doi: 10.3390/ijms20112674. PMID: 31151303Free PMC Article
Patterns of Response and Progression to Immunotherapy.
Borcoman E, Nandikolla A, Long G, Goel S, Le Tourneau C
Am Soc Clin Oncol Educ Book 2018 May 23;38:169-178. doi: 10.1200/EDBK_200643. PMID: 30231380

Clinical prediction guides

Clinical and translational relevance of intratumor heterogeneity.
Goyette MA, Lipsyc-Sharf M, Polyak K
Trends Cancer 2023 Sep;9(9):726-737. Epub 2023 May 27 doi: 10.1016/j.trecan.2023.05.001. PMID: 37248149Free PMC Article
Patterns of Response and Progression to Immunotherapy.
Borcoman E, Nandikolla A, Long G, Goel S, Le Tourneau C
Am Soc Clin Oncol Educ Book 2018 May 23;38:169-178. doi: 10.1200/EDBK_200643. PMID: 30231380
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y, Fukusato T
World J Gastroenterol 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539. PMID: 25400438Free PMC Article
Nephrogenic adenoma.
Amin W, Parwani AV
Pathol Res Pract 2010 Oct 15;206(10):659-62. Epub 2010 Jul 8 doi: 10.1016/j.prp.2010.06.001. PMID: 20619548
Molecular tumour clocks.
Shibata D
Ann Med 1997 Feb;29(1):5-7. doi: 10.3109/07853899708998738. PMID: 9073319

Recent systematic reviews

Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis.
Doherty MT, Sanni OB, Coleman HG, Cardwell CR, McCluggage WG, Quinn D, Wylie J, McMenamin ÚC
PLoS One 2020;15(4):e0232231. Epub 2020 Apr 28 doi: 10.1371/journal.pone.0232231. PMID: 32343732Free PMC Article
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature.
Safa H, Johnson DH, Trinh VA, Rodgers TE, Lin H, Suarez-Almazor ME, Fa'ak F, Saberian C, Yee C, Davies MA, Tummala S, Woodman K, Abdel-Wahab N, Diab A
J Immunother Cancer 2019 Nov 21;7(1):319. doi: 10.1186/s40425-019-0774-y. PMID: 31753014Free PMC Article
Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis.
Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, Cárdenas J, Hernándes, Glazer-Livson S, Jakobsson M, Joronen K, Kiviharju M, Louvanto K, Oksjoki S, Tähtinen R, Virtanen S, Nieminen P, Kyrgiou M, Kalliala I
BMJ 2018 Feb 27;360:k499. doi: 10.1136/bmj.k499. PMID: 29487049Free PMC Article
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.
Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, Pruthi R, Quale DZ, Ritch CR, Seigne JD, Skinner EC, Smith ND, McKiernan JM
J Urol 2016 Oct;196(4):1021-9. Epub 2016 Jun 16 doi: 10.1016/j.juro.2016.06.049. PMID: 27317986
Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
Sylvester RJ, Oosterlinck W, Holmang S, Sydes MR, Birtle A, Gudjonsson S, De Nunzio C, Okamura K, Kaasinen E, Solsona E, Ali-El-Dein B, Tatar CA, Inman BA, N'Dow J, Oddens JR, Babjuk M
Eur Urol 2016 Feb;69(2):231-44. Epub 2015 Jun 16 doi: 10.1016/j.eururo.2015.05.050. PMID: 26091833

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...